Pharmabiz4m
Caristo Diagnostics’ CaRi-Plaque technology, an AI-assisted image analysis application to aid the diagnosis of CAD receives US FDA 510(k) clearance
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
MedPage Today on MSN15h
Stress and Strokes; Gene Hackman's CVD Death; PFO Closure for the Nickel-Sensitive
After transcatheter patent foramen ovale (PFO) closure, patients with nickel hypersensitivity were more likely to develop ...
Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention
FDA 510(k) clearance of Caristo's CaRi-Plaque™ technology advances AI innovator's U.S. commercialization, as it looks to roll ...
Caristo Diagnostics: Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention
FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...
Medical Device Network on MSN17h
FDA clears Caristo’s AI-powered CAD diagnostic software
The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.